...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
【24h】

Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.

机译:内皮舒张因子在环孢素引起的胆碱能和β-肾上腺素肾血管舒张损害中的相对作用。

获取原文
获取原文并翻译 | 示例

摘要

Vascular toxicity is a major adverse effect for the immunosuppressant drug cyclosporine A. The present study sought to characterize the relative roles of the endothelium-derived relaxing factors (nitric oxide, endothelium-derived hyperpolarizing factor [EDHF], and prostaglandins) in the cyclosporine-induced impairment of renovascular responsiveness to acetylcholine receptor or beta-adrenoceptor activation. Changes evoked by cyclosporine in the responses to either vasorelaxant were evaluated in phenylephrine-preconstricted isolated perfused rat kidneys in the absence and presence of N(G)-nitro-l-arginine methyl ester (l-NAME, nitric oxide synthase inhibitor), tetraethylammonium (K(+) channel blocker), or diclophenac (cyclooxygenase inhibitor). Acetylcholine (0.03-2 nmol) vasodilations were significantly inhibited by prior treatment with l-NAME, tetraethylammonium, or diclophenac, suggesting a role for nitric oxide, EDHF, and prostaglandins in acetylcholine vasodilations. Isoprenaline (0.125-4 micromol) vasodilations were inhibited by l-NAME and tetraethylammonium versus no effect for diclophenac. Cyclosporine (1-4 microM) produced a concentration-related inhibition of vasodilations relaxations produced by either vasodilator. Cyclosporine-induced inhibition of acetylcholine vasodilations was attenuated in tissues pretreated with l-NAME or tetraethylammonium but not diclophenac, implicating nitric oxide and EDHF in cyclosporine-acetylcholine interaction. On the other hand, the inhibition of isoprenaline vasodilations by cyclosporine was virtually abolished by l-NAME. In cyclosporine-treated kidneys, exposure to l-arginine, the substrate of nitric oxide synthesis, fully restored isoprenaline vasodilations to control levels and significantly increased acetylcholine vasodilations. It is concluded that the identity and relative contributions of endothelial factors to renal vasodilatory responses as well as to the inhibition of these responses by cyclosporine largely depend on the vasodilator stimulus.
机译:血管毒性是免疫抑制剂环孢素A的主要不良反应。本研究旨在表征环孢霉素-A中内皮源性舒张因子(一氧化氮,内皮源性超极化因子[EDHF]和前列腺素)的相对作用。导致肾血管对乙酰胆碱受体或β-肾上腺素受体活化的反应性受损。在不存在和存在N(G)-硝基-1-精氨酸甲酯(l-NAME,一氧化氮合酶抑制剂),四乙铵的情况下,在去氧肾上腺素预收缩的分离的大鼠肾脏中评估了环孢素引起的对任一血管舒张反应的变化。 (K(+)通道阻滞剂)或双氯芬酸(环氧合酶抑制剂)。乙酰胆碱(0.03-2 nmol)的血管舒张作用可通过事先用l-NAME,四乙铵或双氯芬酸进行治疗而得到明显抑制,表明一氧化氮,EDHF和前列腺素在乙酰胆碱的血管舒张作用中具有一定作用。异丙肾上腺素(0.125-4微摩尔)的血管舒张作用被l-NAME和四乙铵抑制,而对双氯芬酸则无作用。环孢霉素(1-4 microM)对任一血管扩张剂产生的血管舒张松弛产生与浓度相关的抑制作用。在用l-NAME或四乙铵而不是双氯芬酸预处理的组织中,减弱了环孢素诱导的对乙酰胆碱血管舒张的抑制作用,这暗示一氧化氮和EDHF参与了环孢素-乙酰胆碱的相互作用。另一方面,l-NAME废除了环孢霉素对异戊二烯血管舒张的抑制作用。在环孢素治疗的肾脏中,暴露于一氧化氮合成的底物精氨酸可以使异戊二烯的血管舒张充分恢复至控制水平,并显着增加乙酰胆碱的血管舒张。结论是内皮因子对肾血管舒张反应以及环孢素对这些反应的抑制作用的特性和相对贡献在很大程度上取决于血管舒张剂的刺激作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号